Reports of esophageal cancer with oral bisphosphonate use - PubMed (original) (raw)

Reports of esophageal cancer with oral bisphosphonate use

Diane K Wysowski. N Engl J Med. 2009.

No abstract available

PubMed Disclaimer

Comment in

• More on reports of esophageal cancer with oral bisphosphonate use.
  Abrahamsen B, Eiken P, Eastell R. Abrahamsen B, et al. N Engl J Med. 2009 Apr 23;360(17):1789; author reply 1791-2. doi: 10.1056/NEJMc096026. N Engl J Med. 2009. PMID: 19387022 No abstract available.
• More on reports of esophageal cancer with oral bisphosphonate use.
  Solomon DH, Patrick A, Brookhart MA. Solomon DH, et al. N Engl J Med. 2009 Apr 23;360(17):1789-90; author reply 1791-2. N Engl J Med. 2009. PMID: 19391255 No abstract available.
• More on reports of esophageal cancer with oral bisphosphonate use.
  Robins HI, Holen KD. Robins HI, et al. N Engl J Med. 2009 Apr 23;360(17):1790; author reply 1791-2. N Engl J Med. 2009. PMID: 19391256 No abstract available.
• More on reports of esophageal cancer with oral bisphosphonate use.
  Shaheen NJ. Shaheen NJ. N Engl J Med. 2009 Apr 23;360(17):1790-1; author reply 1791-2. N Engl J Med. 2009. PMID: 19391257 No abstract available.
• More on reports of esophageal cancer with oral bisphosphonate use.
  Hofbauer LC, Miehlke S. Hofbauer LC, et al. N Engl J Med. 2009 Apr 23;360(17):1790; author reply 1791-2. N Engl J Med. 2009. PMID: 19391258 No abstract available.
• More on reports of esophageal cancer with oral bisphosphonate use.
  Siris ES, Oster MW, Bilezikian JP. Siris ES, et al. N Engl J Med. 2009 Apr 23;360(17):1791; author reply 1791-2. N Engl J Med. 2009. PMID: 19391259 No abstract available.

Similar articles

• More on reports of esophageal cancer with oral bisphosphonate use.
  Shaheen NJ. Shaheen NJ. N Engl J Med. 2009 Apr 23;360(17):1790-1; author reply 1791-2. N Engl J Med. 2009. PMID: 19391257 No abstract available.
• More on reports of esophageal cancer with oral bisphosphonate use.
  Solomon DH, Patrick A, Brookhart MA. Solomon DH, et al. N Engl J Med. 2009 Apr 23;360(17):1789-90; author reply 1791-2. N Engl J Med. 2009. PMID: 19391255 No abstract available.
• More on reports of esophageal cancer with oral bisphosphonate use.
  Hofbauer LC, Miehlke S. Hofbauer LC, et al. N Engl J Med. 2009 Apr 23;360(17):1790; author reply 1791-2. N Engl J Med. 2009. PMID: 19391258 No abstract available.
• An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
  Haber SL, McNatty D. Haber SL, et al. Ann Pharmacother. 2012 Mar;46(3):419-23. doi: 10.1345/aph.1Q482. Epub 2012 Feb 14. Ann Pharmacother. 2012. PMID: 22333262 Review.
• [Diphosphonate therapy and osteonecrosis of the jaw].
  Løkken P, Skoglund LA, Skjelbred P. Løkken P, et al. Tidsskr Nor Laegeforen. 2007 Aug 9;127(15):1945-7. Tidsskr Nor Laegeforen. 2007. PMID: 17700737 Review. Norwegian. No abstract available.

Cited by

• Epidemiological distribution of high-risk human papillomavirus genotypes and associated factors among patients with esophageal carcinoma at Bugando medical center in Mwanza, Tanzania.
  Ndemela LM, Ottoman OM, Chitemo HD, Minja CA, Rambau PF, Kidenya BR. Ndemela LM, et al. BMC Cancer. 2024 Aug 1;24(1):932. doi: 10.1186/s12885-024-12657-0. BMC Cancer. 2024. PMID: 39090618 Free PMC article.
• Bone Targeting Nanoparticles for the Treatment of Osteoporosis.
  Wen C, Xu X, Zhang Y, Xia J, Liang Y, Xu L. Wen C, et al. Int J Nanomedicine. 2024 Feb 12;19:1363-1383. doi: 10.2147/IJN.S444347. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38371454 Free PMC article. Review.
• Trends in Management of Osteoporosis Following Primary Vertebral Compression Fracture.
  Malacon K, Beach I, Touponse G, Rangwalla T, Lee J, Zygourakis C. Malacon K, et al. J Endocr Soc. 2023 Jun 20;7(7):bvad085. doi: 10.1210/jendso/bvad085. eCollection 2023 Jun 5. J Endocr Soc. 2023. PMID: 37388575 Free PMC article.
• Receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis signaling pathway and related therapeutic natural compounds.
  Qu Z, Zhang B, Kong L, Gong Y, Feng M, Gao X, Wang D, Yan L. Qu Z, et al. Front Pharmacol. 2022 Nov 9;13:1043975. doi: 10.3389/fphar.2022.1043975. eCollection 2022. Front Pharmacol. 2022. PMID: 36438811 Free PMC article. Review.
• Dentistry and Drug Adverse Events: Between Responsibilities and Regulations.
  D'Anna T, Argo A, Zerbo S, D'Urso D, Rini MS. D'Anna T, et al. Toxics. 2022 Nov 7;10(11):671. doi: 10.3390/toxics10110671. Toxics. 2022. PMID: 36355962 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • H1 Connect

• Medical

  • MedlinePlus Health Information